Hilde Lysvand

943 total citations
25 papers, 466 citations indexed

About

Hilde Lysvand is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Hilde Lysvand has authored 25 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Infectious Diseases. Recurrent topics in Hilde Lysvand's work include Psoriasis: Treatment and Pathogenesis (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Dermatology and Skin Diseases (4 papers). Hilde Lysvand is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Dermatology and Skin Diseases (4 papers). Hilde Lysvand collaborates with scholars based in Norway, Finland and Estonia. Hilde Lysvand's co-authors include Ole‐Jan Iversen, Tanel Tenson, Magnar Bjørås, Denis E. Kainov, Valentyn Oksenych, Aleksandr Ianevski, Petter I. Andersen, Anu Kantele, K. Bergh and Astra Vitkauskienė and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Ethnopharmacology and Clinical Microbiology and Infection.

In The Last Decade

Hilde Lysvand

24 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hilde Lysvand Norway 11 156 140 139 91 53 25 466
Oliver Pilgram Germany 7 505 3.2× 182 1.3× 97 0.7× 69 0.8× 64 1.2× 8 696
Miriam Ruth Heindl Germany 6 516 3.3× 166 1.2× 103 0.7× 68 0.7× 68 1.3× 7 719
Daniela Meyer Germany 6 169 1.1× 75 0.5× 76 0.5× 31 0.3× 147 2.8× 7 346
Arjen Companjen Netherlands 14 38 0.2× 215 1.5× 274 2.0× 12 0.1× 38 0.7× 24 497
Brian M. Beyer United States 12 134 0.9× 221 1.6× 54 0.4× 93 1.0× 129 2.4× 19 558
Cynthia Parker United States 14 121 0.8× 422 3.0× 142 1.0× 38 0.4× 542 10.2× 23 920
Anna Maria Perna Italy 9 122 0.8× 168 1.2× 63 0.5× 77 0.8× 116 2.2× 16 457
Mizuki Yamamoto Japan 16 466 3.0× 473 3.4× 163 1.2× 131 1.4× 83 1.6× 42 1.1k
Robin Gross United States 11 247 1.6× 156 1.1× 51 0.4× 47 0.5× 42 0.8× 15 584

Countries citing papers authored by Hilde Lysvand

Since Specialization
Citations

This map shows the geographic impact of Hilde Lysvand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilde Lysvand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilde Lysvand more than expected).

Fields of papers citing papers by Hilde Lysvand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilde Lysvand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilde Lysvand. The network helps show where Hilde Lysvand may publish in the future.

Co-authorship network of co-authors of Hilde Lysvand

This figure shows the co-authorship network connecting the top 25 collaborators of Hilde Lysvand. A scholar is included among the top collaborators of Hilde Lysvand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilde Lysvand. Hilde Lysvand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ianevski, Aleksandr, Hilde Lysvand, Ole Solheim, et al.. (2025). JAK inhibitors remove innate immune barriers facilitating viral propagation. PubMed. 2(2). ugaf017–ugaf017.
2.
3.
Ianevski, Aleksandr, Rouan Yao, Eva Žusinaite, et al.. (2021). Active Components of Commonly Prescribed Medicines Affect Influenza A Virus–Host Cell Interaction: A Pilot Study. Viruses. 13(8). 1537–1537. 3 indexed citations
4.
Ianevski, Aleksandr, Rouan Yao, Hilde Lysvand, et al.. (2021). Nafamostat–Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2. Viruses. 13(9). 1768–1768. 15 indexed citations
5.
Andersen, Petter I., Aleksandr Ianevski, Hilde Lysvand, et al.. (2020). Discovery and development of safe-in-man broad-spectrum antiviral agents. International Journal of Infectious Diseases. 93. 268–276. 185 indexed citations
6.
Ianevski, Aleksandr, Rouan Yao, Mona Høysæter Fenstad, et al.. (2020). Potential Antiviral Options against SARS-CoV-2 Infection. Viruses. 12(6). 642–642. 74 indexed citations
7.
Iversen, Ole‐Jan, Hilde Lysvand, & Geir Slupphaug. (2016). Pso p27, a SERPINB3/B4-derived protein, is most likely a common autoantigen in chronic inflammatory diseases. Clinical Immunology. 174. 10–17. 21 indexed citations
8.
Lysvand, Hilde, Ronny Helland, Lars Hagen, Geir Slupphaug, & Ole‐Jan Iversen. (2015). Psoriasis pathogenesis – Pso p27 constitutes a compact structure forming large aggregates. Biochemistry and Biophysics Reports. 2. 132–136. 7 indexed citations
9.
Lysvand, Hilde, et al.. (2014). Psoriasis pathogenesis — Pso p27 is generated from SCCA1 with chymase. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(5). 734–738. 10 indexed citations
10.
Iversen, Ole‐Jan, Hilde Lysvand, & Lars Hagen. (2011). The autoantigen Pso p27: A post-translational modification of SCCA molecules. Autoimmunity. 44(3). 229–234. 14 indexed citations
11.
Song, Ping, et al.. (2009). Expression of the psoriasis-associated antigen, Pso p27, is inhibited by Traditional Chinese Medicine. Journal of Ethnopharmacology. 127(1). 171–174. 13 indexed citations
12.
Lysvand, Hilde, et al.. (2006). Development and evaluation of a new PCR assay for detection of Pseudomonas aeruginosa D genotype. Clinical Microbiology and Infection. 12(8). 761–768. 5 indexed citations
13.
Ikeda, Shigaku, et al.. (2004). An anti-pso�p27 monoclonal antibody reacts with skin and peripheral blood leukocytes from Japanese psoriatic patients and shows cross-reactivity with SCCA2b. Archives of Dermatological Research. 296(8). 372–374. 4 indexed citations
14.
Jørstad, Størker, K. Bergh, Ole‐Jan Iversen, et al.. (1998). Effects of Cascade Apheresis in Patients with Psoriasis and Psoriatic Arthropathy. Blood Purification. 16(1). 37–42. 8 indexed citations
15.
Lie, Benedicte A., et al.. (1996). Detection of Psoriasis-Associated Antigen pso p27 in Sarcoidosis Bronchoalveolar Lavage Fluid Using Monoclonal Antibodies. Clinical Immunology and Immunopathology. 81(1). 82–87. 12 indexed citations
16.
Iversen, Ole‐Jan, et al.. (1995). The N-terminal amino acid sequence of the psoriasis-associated antigen, pso p27. Archives of Dermatological Research. 287(8). 761–763. 5 indexed citations
17.
Iversen, Ole‐Jan, et al.. (1995). The psoriasis-associated antigen, pso p27, is expressed by tryptase-positive cells in psoriatic lesions. Archives of Dermatological Research. 287(5). 503–505. 15 indexed citations
18.
Iversen, Ole‐Jan, K. Bergh, & Hilde Lysvand. (1993). Use of scale antibodies for the detection of antigens in psoriatic lesions.. Acta Dermato Venereologica. 73(1). 31–34. 14 indexed citations
19.
Bergh, K., Ole‐Jan Iversen, & Hilde Lysvand. (1993). Surprisingly high levels of anaphylatoxin C5a des Arg are extractable from psoriatic scales. Archives of Dermatological Research. 285(3). 131–134. 18 indexed citations
20.
Åsbakk, Kjetil, et al.. (1991). An antigenic determinant is shared by psoriasis‐associated p27 antigen and the Fc part of human IgG. Apmis. 99(1-6). 551–556. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oliver Pilgram Breakdown of academic impact, for papers by Miriam Ruth Heindl Breakdown of academic impact, for papers by Daniela Meyer Breakdown of academic impact, for papers by Arjen Companjen Breakdown of academic impact, for papers by Brian M. Beyer Breakdown of academic impact, for papers by Cynthia Parker Breakdown of academic impact, for papers by Anna Maria Perna Breakdown of academic impact, for papers by Mizuki Yamamoto Breakdown of academic impact, for papers by Robin Gross
Rankless by CCL
2026